IL105325A
(en)
*
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
CN1120310A
(zh)
*
|
1993-03-11 |
1996-04-10 |
塞科雷泰克公司 |
在粘膜表面转运免疫原的聚合粘膜粘合剂
|
AU5543294A
(en)
*
|
1993-10-29 |
1995-05-22 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
US5961970A
(en)
*
|
1993-10-29 |
1999-10-05 |
Pharmos Corporation |
Submicron emulsions as vaccine adjuvants
|
GB9417742D0
(en)
*
|
1994-09-03 |
1994-10-19 |
Univ Nottingham |
Macrophage stimulating composition
|
BE1008977A5
(fr)
*
|
1994-12-27 |
1996-10-01 |
Solvay |
Adjuvants pour vaccins.
|
US5891393A
(en)
*
|
1996-04-09 |
1999-04-06 |
The University Of North Carolina At Chapel Hill |
Method for the microbial decontamination of blood platelets
|
GB9622159D0
(en)
*
|
1996-10-24 |
1996-12-18 |
Solvay Sociutu Anonyme |
Polyanionic polymers as adjuvants for mucosal immunization
|
US6572874B1
(en)
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
US6197327B1
(en)
*
|
1997-06-11 |
2001-03-06 |
Umd, Inc. |
Device and method for treatment of dysmenorrhea
|
US6416779B1
(en)
|
1997-06-11 |
2002-07-09 |
Umd, Inc. |
Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
|
FR2775601B1
(fr)
|
1998-03-03 |
2001-09-21 |
Merial Sas |
Vaccins vivants recombines et adjuves
|
FR2776928B1
(fr)
*
|
1998-04-03 |
2000-06-23 |
Merial Sas |
Vaccins adn adjuves
|
ES2311451T3
(es)
*
|
1999-03-24 |
2009-02-16 |
The Secretary Of State For Defence |
Carbohidratos policationicos como immuestimulantes en vacunas.
|
US6943152B1
(en)
*
|
1999-06-10 |
2005-09-13 |
Merial |
DNA vaccine-PCV
|
US7018638B2
(en)
|
2000-12-19 |
2006-03-28 |
Wyeth |
Mycoplasma hyopneumoniae bacterin vaccine
|
MY129765A
(en)
|
2000-12-19 |
2007-04-30 |
Wyeth Corp |
Improved mycoplasma hyopneumoniae bacterin vaccine
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
CA2513655C
(en)
|
2003-01-21 |
2011-11-22 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
US20110104186A1
(en)
|
2004-06-24 |
2011-05-05 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
EP1765313A2
(en)
|
2004-06-24 |
2007-03-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compounds for immunopotentiation
|
UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
JP5214464B2
(ja)
|
2005-12-28 |
2013-06-19 |
アドバンスド バイオニュートリション コーポレーション |
多糖類、糖類およびポリオール類の乾燥マトリックスを含む、ガラス形態の、プロバイオティクス細菌用送達媒体およびその製造方法
|
JP5394750B2
(ja)
|
2005-12-29 |
2014-01-22 |
ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド |
多価pcv2免疫原性組成物及び当該組成物を製造する方法
|
KR20140019479A
(ko)
|
2005-12-29 |
2014-02-14 |
베링거잉겔하임베트메디카인코퍼레이티드 |
돼지에서 임상 증상을 경감시키기 위한 pcv2 면역원성 조성물의 용도
|
WO2007109812A2
(en)
*
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
US8173657B2
(en)
*
|
2006-03-23 |
2012-05-08 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
CA2647100A1
(en)
*
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Methods for the preparation of imidazole-containing compounds
|
EP2101815A4
(en)
|
2006-12-11 |
2010-10-06 |
Boehringer Ingelheim Vetmed |
Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
|
EP1941903A1
(en)
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxis and treatment of PRDC
|
EP1958644A1
(en)
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prevention and treatment of sub-clinical pcvd
|
US20080292663A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Gerber Jay D |
Adjuvant compositions and methods for delivering vaccines
|
CA2712006A1
(en)
|
2008-01-23 |
2009-10-15 |
Boehringer Ingelheim Vetmedica, Inc. |
Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions
|
ES2467108T3
(es)
|
2008-12-09 |
2014-06-11 |
Gilead Sciences, Inc. |
Moduladores de receptores tipo toll
|
US9603919B2
(en)
*
|
2009-03-31 |
2017-03-28 |
Japan As Represented By The Director-General Of National Institute Of Infectious Diseases |
Method for prophylaxis of influenza using vaccine for intranasal administration
|
PL2435554T3
(pl)
|
2009-05-26 |
2018-01-31 |
Advanced Bionutrition Corp |
Stabilna kompozycja suchego proszku zawierająca biologicznie aktywne mikroorganizmy i/lub materiały bioaktywne i sposoby jej wykonania
|
US9504750B2
(en)
|
2010-01-28 |
2016-11-29 |
Advanced Bionutrition Corporation |
Stabilizing composition for biological materials
|
CN102725393B
(zh)
|
2010-01-28 |
2015-12-02 |
先进生物营养公司 |
包含生物活性材料的干燥玻璃质组合物
|
US20150044242A1
(en)
|
2012-03-12 |
2015-02-12 |
Advanced Bioadjuvants Llc |
Adjuvant and Vaccine Compositions
|
US9120859B2
(en)
|
2012-04-04 |
2015-09-01 |
Zoetis Services Llc |
Mycoplasma hyopneumoniae vaccine
|
UA114503C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv та mycoplasma hyopneumoniae
|
UA114504C2
(uk)
|
2012-04-04 |
2017-06-26 |
Зоетіс Сервісіз Ллс |
Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
|
EP3052516B1
(en)
|
2013-10-02 |
2020-01-01 |
Boehringer Ingelheim Animal Health USA Inc. |
Pcv2 orf2 protein variant and virus like particles composed thereof
|
WO2016001907A1
(en)
|
2014-07-02 |
2016-01-07 |
Prendergast Patrick T |
Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
|
KR102685914B1
(ko)
|
2015-07-29 |
2024-07-16 |
어드밴스드 바이오뉴트리션 코프. |
특수 식이 용도를 위한 안정한 프로바이오틱 건조 조성물
|
EP3801628A1
(en)
|
2018-06-04 |
2021-04-14 |
Apros Therapeutics, Inc. |
Tlr7 peptide conjugates
|
MX2020014087A
(es)
|
2018-07-02 |
2021-04-12 |
Ayuvis Res Inc |
Moléculas inmunomoduladoras pequeñas novedosas.
|